Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Brazil
/
Consumer Retailing
Create a narrative
Dimed Distribuidora de Medicamentos Community
BOVESPA:PNVL3 Community
1
Narratives
written by author
0
Comments
on narratives written by author
11
Fair Values set
on narratives written by author
Create a narrative
Dimed Distribuidora de Medicamentos
Popular
Undervalued
Overvalued
Community Investing Ideas
Dimed Distribuidora de Medicamentos
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Digital Strategy And AI Investments Will Improve Efficiency In Pharma Retail
Key Takeaways Panvel's digital strategy and investment in AI tools boost sales and improve margins through increased efficiencies and tech-savvy customer engagement. Expansion through new store openings and a retail-focused approach is set to drive revenue growth and enhance EBITDA and margins.
View narrative
R$11.80
FV
22.5% undervalued
intrinsic discount
11.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
PNVL3
PNVL3
Dimed Distribuidora de Medicamentos
Your Fair Value
R$
Current Price
R$9.15
100.2% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
8b
2015
2018
2021
2024
2025
2027
2030
Revenue R$8.3b
Earnings R$177.1m
Advanced
Set Fair Value